Sequestration cuts could be offset for Medicare Part D if the U.S. takes advantage of increased use of generics, the Generic Pharmaceutical Association said. The federal government should address obstacles to generic use posed by some Risk Evaluation and Mitigation Strategies, urge the use of generics for low-income Medicare beneficiaries and prohibit state carve-outs. Other proposals include rewarding states that use the least costly drugs for Medicaid, reducing the exclusivity period for biologics and removing disincentives for the use of high-quality, low-cost drugs in outpatient clinics.

Full Story:
RxObserver blog

Related Summaries